
- 积分
- 1343
- 威望
- 1343
- 包包
- 387
|
本帖最后由 细胞海洋 于 2011-7-14 22:01 编辑 , q) k/ ~) v# b7 I! w
& I6 |& e% u9 U' h' B( E. X [hide][/hide]
; ?; _& y3 ^3 PVirology - Principles and Applications
5 c% {3 f. g- h5 B* b5 _Dr John Carter (Liverpool John Moores University, UK), Prof Venetia Saunders (Liverpool John Moores University, UK)
, t2 b( `) f6 q) M5 a" x/ d+ [August 2007, ©2007* t% r& a8 f1 D k6 i" m: [# f
by Dr John Carter, Prof Venetia Saunders+ @) ]0 D8 M7 S2 r7 M9 n
ISBN 978-0-470-02387-7
) k7 ~! y5 J/ H: _) [Preface.
: p: l8 A8 o1 c1 w6 B$ R
' D/ C8 A9 K' r- w+ r5 U# aAbbreviations used in this book.5 E0 L. n' Q4 e' m/ j) w, j1 I
: ?: R3 G, O( d7 X& x* sGreek letters used in this book.* o- D; ^/ `; N3 N& M" J Y
4 z* |' n- S, b& R( f! P O
Colour coding for molecules.
: x2 Z. y8 d* ^' @* Z. e: n/ ~& g' s2 n$ l3 X0 w' L
1 Viruses and their importance.
$ u; J5 [! J: f: j2 E9 h+ |) s+ A8 t* Z; \, N' Z; H6 _
1.1 Viruses are ubiquitous on Earth.
: A- j& `9 v8 f+ A5 e9 P' y! N' ~+ E2 G5 ?8 k0 i7 t' O
1.2 Reasons for studying viruses.: V4 \& ?! J3 J# j
$ u* f0 l& A& s1.3 The nature of viruses.
" }' t7 ^% p& ^' z. L' x! x( ~
& | X( D" d* ~! t C1.4 The remainder of the book.: Y' V1 I$ D) H- i& T6 I7 r6 F3 b2 l
% Q- N% I6 @1 C9 ~0 }* z
2 Methods used in virology.
2 L. | w2 ?! R/ n2 @* t7 [& N- n6 d, _ x* f- b8 Y& y- ~
2.1 Introduction to methods used in virology.
9 e0 X. } l8 [, i
: t/ ]+ E% _7 a* ^. M2.2 Cultivation of viruses.
2 y( b" h) X/ i5 S7 D& J4 c- A) k6 |1 L6 A" i9 i# N
2.3 Isolation of viruses.6 t' \6 J! X+ N
+ o6 C" O* }4 [
2.4 Centrifugation.
6 I' m8 ^) l, _7 G( ^( j# x8 I7 r( V9 c: y
2.5 Structural investigations of cells and virions./ R( P$ [% l1 n
, u n' O$ R+ G4 u1 @
2.6 Electrophoretic techniques.* C( i* X3 w3 w6 p7 b* Z
" y9 p9 f6 E. G% y; ]$ T
2.7 Detection of viruses and virus components.( I9 Z( |6 }' s9 I
1 u2 h7 z% G9 J: N: f
2.8 Infectivity assays.
3 u" F& O7 G# T1 c4 O$ n( |+ }$ ~9 t
' x4 Z5 L/ X/ H2.9 Virus genetics.& J$ F b5 K+ i- _
6 K' `. G, ~) n
3 Virus structure.% v& k9 j# L! b5 S/ z% [
' W' `9 {5 R; N
3.1 Introduction to virus structure.
0 E0 v, R6 Z7 r& m8 w
6 x' H: w7 X* T7 C% V3.2 Virus genomes.
0 }0 w3 O0 F# j* r4 M
8 D, t, @! z0 u# Y3 x; q, Y3.3 Virus proteins.
$ P) D0 ^% x5 M; J' ]* N( z# F/ Z& S# \/ C$ \. O0 K: B
3.4 Capsids.
- r! P8 f7 `" D u- r; W
2 n% f* K1 p/ s1 I0 Q1 y3.5 Virion membranes.& ^# ]2 G' J) P4 ?0 Y6 {' ^
4 O/ Q, ^* t- e9 |
3.6 Occlusion bodies.
! }) J, I' N" t6 r* D
* F! e# m; O- A M( e( \( ^3.7 Other virion components.
* I6 j# L4 a% d& y- q
( s6 U; n1 J) e X" [& x4 Virus transmission.* M" x+ ^: R* y' w. Q
$ r5 i% u$ V2 V4 P4.1 Introduction to virus transmission.5 R+ M! V, H. A( y+ g. s, N
! u( i8 C5 B: x: g( F4.2 Transmission of plant viruses., v, j" M6 j" o7 Z; }% s8 l
; e8 B# B& `& @4.3 Transmission of vertebrate viruses.
G( j6 w8 h% }& V/ a
! m: _( P& Q% q q. F4.4 Transmission of invertebrate viruses.
' |5 y8 C& @7 n$ ]5 N
; b4 ~) W0 p% d6 \% L% U4 r: C& K4.5 Permissive cells.; c, L/ ~* c" n6 G) t- E5 T- _* S
& k! r5 V+ u9 ?7 K) D1 \5 Attachment and entry of viruses into cells.
3 @- v, Q. D0 ~+ k! x, F1 F4 s6 T
/ q( ~4 K k" n1 P3 \# o; m5.1 Overview of virus replication.0 I( g2 M4 m0 t2 G
. C0 |: m# b' K( A9 k) ?) b
5.2 Animal viruses.
/ _/ w4 I9 r+ I" D5 o. o; J# @' K* Q7 h- x0 l3 i8 [
5.3 Bacteriophages.
( y8 O4 n0 p- e6 G9 F5 S7 J9 U+ i! W9 i
6 Transcription, translation and transport.4 t6 j( I' B) W, J5 g- ?, S& J
( ]" i4 k( [) S" H( W
6.1 Introduction to transcription, translation and transport.$ t. o$ R% z8 A# ?7 r
" H( W* w Q- k4 M6.2 Transcription of virus genomes.
+ u# B% G H: S; ?6 Y' q8 V
/ e% Z+ I# |0 Q! n+ o9 R8 g6.3 Transcription in eukaryotes.2 Y- @3 R& t) J0 ^) ~# ]8 y
4 f8 q+ {) s! @7 E% U D6.4 Translation in eukaryotes.
; K$ {+ \6 R/ Z
- X/ _; a4 T: [' C% u$ K i. e% C6.5 Transport in eukaryotic cells.0 V6 L7 H" c% Y" q, Z/ G
0 M/ r0 F) o9 k V3 s* n6.6 Transcription and translation in bacteria.! W v6 Y3 S" J7 w( D j
2 H9 t7 \+ u/ Y, x* X7 W
7 Virus genome replication.
3 g) K' Z0 b9 F4 V7 H6 e2 R% s+ X0 A D& c# s h+ K- d
7.1 Overview of virus genome replication.
9 F7 n5 ?4 y U ?7 {) f: W, W( u1 j; V8 B$ ~2 W
7.2 Locations of virus genome replication in eukaryotic cells.
( I/ U- a9 w- c, H* |; \5 q7 L4 _
3 |5 f) _$ _9 } s' e6 G+ P7.3 Initiation of genome replication.1 P" ?1 T) Q! A' U) k" t9 q$ ?6 [3 m
1 O4 P* T+ U( B* s8 Z/ N0 u3 x7.4 Polymerases.
5 u i/ c) o, P+ l& B6 j# r4 F3 G7 ]+ b; s% {4 n
7.5 DNA replication.
+ K" P6 V4 i$ Z
: y5 U- t) Y7 V4 ]: a- s/ [7.6 Double-stranded RNA replication.: {+ G* R4 x9 }# ~& Q# S2 W2 F
1 r: K) A/ G* F1 \8 q; f7.7 Single-stranded RNA replication.5 l% W* F% R- ?9 z% y8 K
6 [6 u* W+ h* L4 ~. T. k7 o- H
7.8 Reverse transcription.
7 ]" R O! ^9 E) G# Y: y1 Q$ Q$ ^% H/ I, E) a; S, t+ W
8 Assembly and exit of virions from cells.; Q1 Z' n3 V! Q& O
6 d3 }) \! T& \, S z
8.1 Introduction to assembly and exit of virions from cells.
7 T1 k, q+ X" \8 d7 T% ?# X8 h; C! F% E2 w1 X3 t% \
8.2 Nucleocapsid assembly.
& t0 D! P5 s( }* E# Z7 P
+ c+ \% B/ Q' O9 }. V0 y8.3 Formation of virion membranes.
1 ?5 P5 c# m3 m+ n- j
( b3 B8 ?9 t \6 ], i" n5 ]/ m' n8.4 Virion exit from the infected cell.9 h1 z- ]; p# Z- n: I g
# ?% _1 {# |/ Y( P( y
9 Outcomes of infection for the host./ U/ C; @5 |) k1 t
0 N! I5 t6 Q6 [( Z
9.1 Introduction to outcomes of infection for the host.
; }" ^8 Z- k$ z5 k8 L( c( p& S& r2 K( y% p. w) A
9.2 Factors affecting outcomes of infection.7 B3 G f8 b/ s: z
4 r8 F6 c& ~; B2 h8 A
9.3 Non-productive infections./ ~, S5 c e7 E+ _- o( O0 b+ _
: t8 p n# G8 F1 P5 G4 r
9.4 Productive infections.+ _" q2 Q0 y" k' m
. ~3 b' Z" q. @+ ~( w
10 Classification and nomenclature of viruses.# P$ H& T/ v% C% F1 d
. J G1 K( L S$ j6 J1 k/ z
10.1 History of virus classification and nomenclature.6 ^5 ^9 v0 h- w) [: s3 ~$ F
) O2 n" Y* T, y, c9 u* W' @2 w
10.2 Modern virus classification and nomenclature.4 g* d0 O* f. b
% W- g) [! }0 \$ N9 @' y
10.3 Baltimore classification of viruses.
" H2 [7 _. ^8 `* }% P
4 W8 @* A2 F: T. J0 P11 Herpesviruses (and other dsDNA viruses).
- H7 L' x" E+ E' Y
: M2 I& l5 X& T: D+ B' _4 t11.1 Introduction to herpesviruses.3 a' J3 u, V' W* b! B# ?
1 R- Z K" a0 A$ g S# |9 J
11.2 The human herpesviruses." O$ i) @. ~$ Q$ T0 E) r/ N
2 V7 B3 S( Z& V5 s. X9 d8 ?3 H& }11.3 The herpesvirus virion.9 H' Q. L: J7 i- N
1 w7 Q. {9 \: e4 f% B
11.4 HSV-1 genome organization.
$ V& P! @% _( ^! x! c9 r
0 @* |( Z: V4 N _0 w O$ a6 m& e! Z11.5 HSV-1 replication.: C3 ?* F' |" V) j4 P
8 x6 j3 N0 f% Q% L0 K/ g" J- C
11.6 Latent herpesvirus infection.& s9 b, u4 V3 G/ l% R( i
6 U- Q. v: v$ Z6 L11.7 Other dsDNA viruses.
6 B0 k+ i+ T! }" E- F& A: ^1 x( I' Q
12 Parvoviruses (and other ssDNA viruses).
+ Y; p+ ?! q2 w4 c9 o6 U( [- I: }; A$ ~2 V. c4 d: q7 L# R
12.1 Introduction to parvoviruses.5 n' R! R0 L: D' V! } M
3 G7 N: A }# _) g12.2 Examples of parvoviruses.' V" \0 K/ t/ S: f- r( W3 V$ _
+ i" I( W4 |0 u& y) f12.3 Parvovirus virion.5 T: I z8 M/ t* t1 s+ J2 U8 V
4 b' p/ S) H( H2 w$ j- Y- X
12.4 Parvovirus replication.
# g5 v% b4 y* [- n8 k& `0 Y" E3 ?( S2 r& Q' q
12.5 Other ssDNA viruses.
}9 F! R; o2 r
x, ~' d- B- T+ P. U+ l) `13 Reoviruses (and other dsRNA viruses).
7 C' E; ]; u+ ?% p# K
7 I5 N+ M/ w5 h& {9 f+ a: s13.1 Introduction to reoviruses.8 L1 J5 q* e M4 N& j) S
$ g3 H7 \, G; ?- t3 c( {13.2 Rotavirus virion.
5 ?) d s- _( T: }5 B) i. {' _9 k2 R( `/ D# C0 w( V: }+ S
13.3 Rotavirus replication.6 X7 P' b1 E/ U( _1 K
& P/ b/ n6 z! ~& Q9 ]% L
13.4 Other dsRNA viruses.
/ m4 v3 y/ R0 y' ^% ^" p" K& w, j8 s
14 Picornaviruses (and other plus-strand RNA viruses).
; Y5 |( }8 I% H: U, ~ T8 w3 |& A& ^' P
14.1 Introduction to picornaviruses.
2 b1 x1 B3 |' s# i; A9 h3 h1 `' A8 x, w! O; ]- P) [2 x' G
14.2 Some important picornaviruses.
' J" [3 `. P. j2 z" C+ f( o% x' g+ Y3 @* Z" Q6 C, }
14.3 The picornavirus virion.
5 X6 W! ^* I/ y
% ^+ w; `9 U; E' p- f14.4 Picornavirus replication.
) w2 ?" ~' U# a* c. `7 k2 W, D& ]
14.5 Picornavirus recombination.3 t+ J6 [$ o: \ E. s
) l# D+ s5 q, T14.6 Picornavirus experimental systems
! |' P! T. i2 g0 W! p& l$ e9 q
14.7 Other plus-strand RNA viruses.% \: ?4 P# b( n6 v
1 J7 p+ ^0 ?( G( q& e/ [. p# S
15 Rhabdoviruses (and other minus-strand RNA viruses).' q" Q5 ]* j1 L
0 t3 I/ g0 x- |% H, w) P6 a( u5 f
15.1 Introduction to rhabdoviruses.* _6 M7 R: v6 ]; |
6 N T6 E- l3 y& q0 u# j; L
15.2 Some important rhabdoviruses.4 c$ v3 B0 b D! o# g5 ]2 g
+ U: B, E% C) u
15.3 The rhabdovirus virion and genome organization.. v+ D5 J5 D+ l: S* S/ A
) F$ m$ c5 r0 U- A15.4 Rhabdovirus replication.
' G4 x$ j& h G6 D! F- i9 O- _" H) E
15.5 Other minus-strand RNA viruses.
- A F2 M F$ V }* R- K. ]( _3 F2 h$ n ?% }
15.6 Viruses with ambisense genomes.
5 M E3 S2 `7 x; f9 Q! |3 Z
# d: Z: E, P A+ l15.7 Reverse genetics.
, h* X/ v2 ]. z/ W9 S# G0 _, p+ c/ B0 g) Z$ o6 l0 i8 z
16 Retroviruses.3 d8 j4 _8 D6 ~( i6 c
# r/ A* I' J: Z) ]2 |3 u, j16.1 Introduction to retroviruses.7 ?3 d8 F% o' U2 a! E5 o, y g
5 x( w- Q! N4 X2 ?16.2 Retrovirus virion.+ I9 N* |0 D2 f0 ]2 ~- ~2 a
2 m, j: r7 T5 S- g
16.3 Retrovirus replication.5 U8 j2 a* w1 Q0 k" y6 _
' i; I) r; \# V. `4 Z# o
16.4 Examples of retroviruses.1 Z0 B, z- R* A" R9 ^! `& R
1 ^& i; n- N* W+ B16.5 Retroviruses as gene vectors.2 R9 z7 h4 T, E) u0 _; h2 X7 w
' ]7 h7 w' k+ h0 o: t16.6 Endogenous retroviruses.
* w: f- Y* c1 I- z, J4 U( a
" J* u: u$ Y0 g" u& G# Z17 Human immunodeficiency viruses.$ K! K6 g' s9 s( c- T6 X+ {, j
: z+ i8 P6 J/ O
17.1 Introduction to HIV.
- y$ c. H2 n; ~/ X
# Q: ]9 o0 N4 [0 t! j$ G; J17.2 HIV virion.6 e' K3 l6 ~/ h) t8 {
1 x3 x0 e: n/ r' R. e17.3 HIV genome.& T9 ^% q. u5 P! Q2 u) U, t
0 h- j8 L% ?- }$ p( J8 E. u: L3 ^4 U, c17.4 HIV-1 replication.3 Z$ O0 {1 |+ {- |" G
# |) P$ t, X# F% @; K
17.5 HIV-1 variability.
$ a$ j4 s& ^# i: X/ H& |2 ]( S' d
17.6 Progression of HIV infection.
2 Z' x7 J: {! C$ |% x3 P# L
D/ e5 d+ I' i- C: [ q17.7 Prevention of HIV transmission.% B+ ^8 G S" G4 z; D
; Z0 Q# u/ E5 f+ p0 A, Z# H
18 Hepadnaviruses (and other reverse-transcribing DNA viruses)." X3 {* o' g/ m( d
X. F2 Y9 o( l; z
18.1 Introduction to hepadnaviruses.; {! _) N6 _% P
. i. s5 k, B: Z W' K
18.2 Importance of HBV.
0 [6 x1 |0 c9 i( G- f0 i) p( I* h2 D8 X6 v9 Z" m
18.3 HBV virion.1 f5 ?9 ~3 k6 }7 G
# V, f/ O' X5 s5 f2 [- G5 j18.4 Non-infectious particles.
1 p5 Y0 | H3 H! B- o& J6 b7 P3 a% K% W9 q" m
18.5 Soluble virus protein.( h1 i0 ]) n) g' U
2 W0 ~) _/ @9 Y& }0 f
18.6 HBV genome.# v2 x, Z+ ?$ S
" v! a, D" S) B! Y+ p
18.7 HBV genetic groups.3 q | T7 m1 g3 F( d- k# V
9 E( r8 p& x* ^
18.8 HBV replication cycle.
5 J+ D6 f9 d* B% E% i/ ^
9 X- e: h( n5 P6 N6 q9 r+ B9 i1 H/ G18.9 Prevention and treatment of HBV infection.
9 U5 f0 H/ A/ H, z$ l0 r
+ l: f) O8 {) f18.10 Other reverse-transcribing DNA viruses.
+ K! q* m' }% y6 a! g: i: r* Z: V0 E! z9 E3 e
19 Bacterial viruses.
( z/ D8 U! h' t( R% r
- K0 T3 u+ e" D' F0 ?& z% C19.1 Introduction to bacterial viruses (bacteriophages.
' V! `/ ~- N+ j. `
' R' z; Y3 \, z0 hRNA PHAGES.8 q& x7 E2 M, l+ A1 s: R
5 w. [' H/ E+ C0 S( c
19.2 Single-stranded RNA phages.* ~+ p8 E7 X& H( I* O
/ `* h# [- D" \ L, o1 D
19.3 Double-stranded RNA phages.
6 G( g# k2 f" y. J: b2 ^3 L5 |( H
: U. w3 _: F" Y/ P4 Z" s4 p# hDNA PHAGES.6 ?& i/ b/ P" G$ y$ Y
- C& I1 J `, R$ @1 E) I19.4 Single-stranded DNA phages.
7 C+ ]0 m# j$ |( m" W+ Q9 N! j- }$ u) L
19.5 Double-stranded DNA phages.
6 h! c# s2 d* |" g3 W9 h; R* |/ _7 H* J) O+ c
20 Origins and evolution of viruses.
) s1 {, t5 e' I/ _+ O9 B
& _# h3 [* l: n$ E: _/ N' V L# N7 r21.1 Introduction to origins and evolution of viruses.6 L& Y* W# i3 [+ D2 h
# Y6 @4 V9 c3 \20.2 Origins of viruses.
: y6 ?. m4 Q; G, [
7 w* h1 P. @* \% N( N20.3 Evolution of viruses.6 l9 c1 q: v$ }1 A( P, m
; W' t; v4 e) A2 M21 Emerging viruses.: x S3 E: O* h, K# ~4 N( f' ]
/ d3 A* [! }; e. C" x& {21.1 Introduction to emerging viruses
8 w6 Z! v. {0 q) e: z9 w. T# o" r5 o" X
21.2 Viruses in new host species6 ?* x* m& U. |$ x3 Q
/ g- O6 `9 a$ h6 a21.3 Viruses in new areas( e c" e' s1 t. A8 a: \- f
1 `% \+ u" X( e9 x" S+ S. l/ F1 g
21.4 Viruses in new host species and in new areas
1 ~7 C0 i* a* M, T, c1 b2 c( D% _1 f7 c7 i) a* a3 B" I6 [
21.5 New viruses
: f- S. c5 ?2 U H, K2 @2 c
9 ^# W& m8 `+ _3 K* e. |21.6 Recently discovered virus
9 r: x5 w T2 \
$ R+ {7 U+ i5 |1 ^& t) g/ h) H6 X5 T21.7 Re-emerging viruses. n9 Q, f+ U" U1 J: i4 g- ]
9 F C* Z3 S3 k4 \- w21.8 Virus surveillance
4 w% r1 G9 h* P' K# m$ [! h( q. [" k3 }3 H
21.9 Dealing with outbreaks2 e% P( y0 t6 O9 N, ~! H
2 m0 V, C8 s+ \% z7 c8 C6 g% `22 Viruses and cancer
7 E |" j' C N! E* u u( [' k
& N6 _4 z2 b/ a22.1 Introduction to viruses and cancer
4 X* t& h% Z5 \9 V0 ?& ~
/ O6 n$ y2 S% Y ?8 E$ b6 S" r22.2 Papillomavirus-linked cancers% i5 o, s* @/ v
2 d P7 ~4 N5 J* [0 v6 Z0 y22.3 Polyomavirus-linked cancers
' b8 h; L+ ~2 x" [5 H+ f. v3 E; [) i u( l/ V) E
22.4 Epstein-Barr virus-linked cancers9 H9 }3 z3 {4 X" f
+ M& |5 V( o6 G _* D- Y; z
22.5 Kaposi’s sarcoma" g" k- Z+ [# H; d; r: P( U h
# l( e0 _5 N- |* ]% _6 o22.6 Adult T cell leukaemia
/ m- `' _& {5 q0 o: y
! e- H2 {5 j2 ^! S9 \8 I22.7 Hepatocellular carcinoma: h z% O! _5 C
4 r" V8 j6 |+ [! v# Q22.8 Virus-associated cancers in animals( {, O! q/ M5 n m/ d1 ~
. R7 ]# |" v8 g& {6 a0 I
22.9 Cell lines derived from virus-associated cancers.$ |4 B' ~- |# n2 I; U, b
1 f$ P* [4 X. S22.10 How do viruses cause cancer?* i- y; t7 w$ z c) e
( C6 G) \7 S) ^+ V* Z
22.11 Prevention of virus-induced cancers.
9 D5 e% x* w7 B' D% s$ D- D5 V, @7 b1 I6 I! ^% I- i" z
23 Survival of infectivity.
) ^% e# V& F6 @! {/ Z
0 j7 @. m3 N6 Q23.1 Preservation of virus infectivity.2 r' s! I: `$ r' J& p' r; V
) x0 r1 f6 z: n23.2 Destruction of virus infectivity.
v% |# Y( p& {4 E8 O z/ T2 r) \2 v% n
23.3 Inactivation targets in virions." a( H# s! T6 ]- b: }+ o/ }% H4 m
6 c' @* s- Y% x: C# X# T G
23.4 Inactivation kinetics.
0 X$ n. }% @3 k% [
% g5 \2 y2 x# z" ` u9 T1 D23.5 Agents that inactivate virus infectivity.
1 `. c6 ~/ \' G' w- m
8 `' s" C1 Z; q. `2 M$ x9 a24 Virus vaccines.
7 X4 L3 m6 o& H1 T" X/ {! [* [0 n; E7 h
24.1 Introduction to virus vaccines.6 q6 O& z( t# u) E$ D! A5 p
+ t8 B4 E* L3 f/ j2 Q# N$ R24.2 Live attenuated virus vaccines.
& H; C. M+ e( R; m: o6 Q" z9 ?' S( i0 K( ]$ T
24.3 Inactivated virus vaccines.) M$ ]9 }7 d" W% B2 h
7 m' \; l; d* y& A24.4 Virion subunit vaccines.
7 Z: R4 I8 J! t3 N
1 i( A! J. {; ^/ y! B) p" t7 U24.5 Live recombinant virus vaccines.
4 R/ q9 B# r, V. W& K9 M7 R' s8 _1 F& E7 m, k- N1 x
24.6 Mass production of viruses for vaccines.
! X) C' k" R4 M. C# E( `( }8 U0 E8 e2 x
24.7 Virus-like particles.3 H7 t# k |& u! H
8 x! {: s3 Q: a! Q24.8 Synthetic peptide vaccines.; a1 i+ Z1 J- ~/ t7 G3 C; \
; K$ D2 a& g7 [5 c& H+ ?( o- J24.9 DNA vaccines.' l" T0 T& \, y9 | r: Y6 z
6 Q7 Z$ y+ P0 L+ X; h24.10 Storage and transport of vaccines.9 `5 A- o% Z# H
4 {3 T# Y' Z5 Q9 V
25 Anti-viral drugs.
# U5 q: _0 z' l! ~
1 e3 T3 a( o1 S& [25.1 Introduction to anti-viral drugs.
& Z. I8 `. }1 l: H$ C$ a4 Q. u6 u1 F- ]0 H& O+ R
25.2 Development of anti-viral drugs.# t7 Y/ Q" _6 \ z$ j
/ \4 p5 [( S1 h7 L2 I0 C$ I25.3 Examples of anti-viral drugs.
( A# U& m+ y1 I% D" ~
+ l; N6 _# X8 g" [3 l25.4 Drug resistance.
, m' C+ o7 I: p+ A: V
" S# c$ J$ O8 z& b" G3 Q25.5 Anti-viral drug research.! Z4 k, r7 _' f% F4 H; [; S+ x% v
, n( U1 d: a& ^$ C$ D1 c% @
26 Prions.
! Q% G' w- Y( t# `
( I7 {3 C" t5 Z26.1 Introduction to prions.
$ G# `1 X# B* T4 c; Y- j) J, {: P. F& w
26.2 Transmissible spongiform encephalopathies.
( i7 I4 @8 w9 Z
% v6 y$ f$ ]8 \7 z2 g! u26.3 The nature of prions.2 |& Q: I' K: O4 j3 O: i0 r. r
+ z, m. p5 R0 h5 J! ^4 \7 h26.4 Prion diseases.
! L& X1 e9 B" B7 p/ X* m) x; v& D" @* G
26.5 Prion strains.) w$ X. X4 p' e
3 n; m0 Q+ n; k& ~+ J5 B" x
26.6 Prion transmission.
5 {" H% i, N& c3 Z
: B. x0 N2 G0 B; T( M- R* K26.7 The protein-only hypothesis.
2 c* k- {( E9 H0 b, a
6 @( L' S5 v2 N% ^! g+ m* ?% _/ [Learning outcomes.
/ O* Z! d% p) e" l0 h" X$ G; k- R* \$ _% ?
Sources of further information.) F$ ^! v- X0 ~3 Y- c3 q9 [
$ E0 A" [9 Q# R; a. Y B. v1 gVirologists' vocabulary.
8 D- ]% c* A- S4 l% O$ b3 T0 q, o) L8 [& B8 s( ~
Index. |
附件: 你需要登录才可以下载或查看附件。没有帐号?注册
-
总评分: 威望 + 4
包包 + 15
查看全部评分
|